Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Vomiting × dolasetron × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 1 Neoplasms 1 Nausea 1

Interventions

Dexamethasone 18 Palonosetron 14 Aprepitant 14 Ondansetron 10 Calcium Dobesilate 9 Granisetron 7 fosaprepitant 5 dexamethasone acetate 5 Doxorubicin 4 netupitant, palosentron drug combination 3 dexamethasone 21-phosphate 3 Olanzapine 3 Cyclophosphamide 3 netupitant 2 Vincristine 2 Therapeutics 2 Surveys and Questionnaires 2 Sugars 2 Metoclopramide 2 Mesna 2 Ifosfamide 2 Fluorouracil 2 Dronabinol 2 Diphenhydramine 2 Cisplatin 2 rolapitant 1 phenazine 1 ginger extract 1 dolasetron 1 casopitant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01636947 2018-09-25

KMEC

Merck Sharp & Dohme LLC

Phase 4 Completed

494 enrolled 14 charts

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡